Steris (STE) FCF Payout Ratio Growth (1y) (2019 - 2026)
Powered by 
Analysis
Steris (STE) FCF Payout Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | -16.90% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | -54.18% |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | -8.00% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 27.54% |
| 10 | Zimmer Biomet Holdings | 18.11 Bn | 17.70 Bn | 1.54 Bn | -18.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.54% |
| Mar 31, 2026 | -14.53% |
| Dec 31, 2025 | 34.49% |
| Sep 30, 2025 | -18.67% |
| Jun 30, 2025 | -34.48% |
| Mar 31, 2025 | -6.33% |
| Dec 31, 2024 | -22.63% |
| Sep 30, 2024 | -53.77% |
| Jun 30, 2024 | 21.42% |
| Mar 31, 2024 | -2.49% |
| Dec 31, 2023 | -27.70% |
| Sep 30, 2023 | -63.34% |
| Jun 30, 2023 | -41.72% |
| Mar 31, 2023 | -26.02% |
| Dec 31, 2022 | 56.48% |
| Sep 30, 2022 | 390.05% |
| Jun 30, 2022 | -55.38% |
| Mar 31, 2022 | 44.54% |
| Dec 31, 2021 | 17.33% |
| Sep 30, 2021 | 57.67% |